Health / Medical Topics

    Oncogene E1A

    Viral Oncogene E1A encodes E1A Protein, a regulator of early viral gene transcription. E1A interacts with diverse cellular proteins to override host cell controls of cell cycle, differentiation or apoptosis. E1A reprograms gene expression and other processes, which leads to transformation. E1A interacts with general and specific transcription factors, co-activators and chromatin-modifying enzymes. Targeted proteins include pRbs, p300/CBP, cyclin/Cdk, transcriptional corepressor CtBP, YY1, RACK1 and SWI/SNF complex, as well as cAMP/PKA signal components. E1A N-terminus binds pRb and p300/CBP regulators. E1A C-terminus negatively modulates the N-terminus and interacts with CtBP. By binding COUP-TF repressor and decreasing NF-kB Class I enhancer binding, E1A can repress MHC Class I gene transcription and allow tumor cells to avoid lysis by cytotoxic T lymphocytes. E1A also determines susceptibility to NK cell lysis. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Human oncogene DBL is a mutated form of the MCF.2 cell line derived transforming sequence (MCF2) gene, located at Xq27, which encodes…
    Human colony stimulating factor 1 receptor (CSF1R) gene, located at 5q33.2-q33.3, encodes macrophage colony stimulating factor I receptor protein. Mutations in this…
    A transforming gene activated in certain human B lymphoid tumors, B-lym was originally detected by transfection of NIH 3T3 cells with DNA…
    Human transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) (TFAP2A) gene, located at 6p24, encodes transcription factor AP-2 alpha. This…
    Any DNA sequence alteration process occurring in a proto-oncogene, resulting in loss of regulation of the gene product, and predisposing the cell…
    Human v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1) gene, located at 9q34.1, encodes proto-oncogene tyrosine-protein kinase ABL1 protein. Alternative splicing…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact